Although AML with PML::RARA represents about 95% of APL cases in clinical practice, to further study the generalisability of MC-100i in the early screening of APL, a multicentre study with more APL cases and more variant APL types could be considered for future research. Here, PML is linked to acute myeloid leukemia.